GB1311956A - Method of potentiating the activity of phosphonomycin antibiotics - Google Patents

Method of potentiating the activity of phosphonomycin antibiotics

Info

Publication number
GB1311956A
GB1311956A GB4606370A GB4606370A GB1311956A GB 1311956 A GB1311956 A GB 1311956A GB 4606370 A GB4606370 A GB 4606370A GB 4606370 A GB4606370 A GB 4606370A GB 1311956 A GB1311956 A GB 1311956A
Authority
GB
United Kingdom
Prior art keywords
phosphonomycin
bacteria
antibiotics
activity
potentiating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4606370A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1311956A publication Critical patent/GB1311956A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB4606370A 1969-10-02 1970-09-28 Method of potentiating the activity of phosphonomycin antibiotics Expired GB1311956A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86335169A 1969-10-02 1969-10-02
US7124770A 1970-09-11 1970-09-11

Publications (1)

Publication Number Publication Date
GB1311956A true GB1311956A (en) 1973-03-28

Family

ID=26752007

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4606370A Expired GB1311956A (en) 1969-10-02 1970-09-28 Method of potentiating the activity of phosphonomycin antibiotics

Country Status (7)

Country Link
BE (1) BE756953A (fr)
CA (1) CA943067A (fr)
DE (1) DE2048375A1 (fr)
FR (1) FR2070104B1 (fr)
GB (1) GB1311956A (fr)
IL (1) IL35334A (fr)
NL (1) NL7014541A (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT383735B (de) * 1984-10-05 1987-08-10 Schering Spa Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen
AT383736B (de) * 1984-10-05 1987-08-10 Schering Spa Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen
US5520926A (en) * 1992-03-17 1996-05-28 British Technology Group Limited Method of using mannose phosphates for the treatment of fibrotic disorders
GB2299025A (en) * 1992-03-17 1996-09-25 British Tech Group Formulations of mannose phosphates useful in the treatment of fibrotic disorders
US7470699B2 (en) 2003-07-11 2008-12-30 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7812159B2 (en) 2005-01-10 2010-10-12 Arena Pharamaceuticals, Inc. Processes for preparing aromatic ethers
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US8362248B2 (en) 2005-01-10 2013-01-29 Arena Pharmaceuticals, Inc. Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
US10894787B2 (en) 2010-09-22 2021-01-19 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
US11884626B2 (en) 2015-06-22 2024-01-30 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190116416A (ko) 2017-02-16 2019-10-14 아레나 파마슈티칼스, 인크. 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT383735B (de) * 1984-10-05 1987-08-10 Schering Spa Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen
AT383736B (de) * 1984-10-05 1987-08-10 Schering Spa Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen
US5520926A (en) * 1992-03-17 1996-05-28 British Technology Group Limited Method of using mannose phosphates for the treatment of fibrotic disorders
GB2299025A (en) * 1992-03-17 1996-09-25 British Tech Group Formulations of mannose phosphates useful in the treatment of fibrotic disorders
GB2265310B (en) * 1992-03-17 1996-09-25 British Tech Group Treatment of fibrotic disorders with mannose phosphates
GB2299025B (en) * 1992-03-17 1996-11-27 British Tech Group Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye
US8933083B2 (en) 2003-01-14 2015-01-13 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US7838525B2 (en) 2003-07-11 2010-11-23 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US8546429B2 (en) 2003-07-11 2013-10-01 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7470699B2 (en) 2003-07-11 2008-12-30 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7812159B2 (en) 2005-01-10 2010-10-12 Arena Pharamaceuticals, Inc. Processes for preparing aromatic ethers
US8362248B2 (en) 2005-01-10 2013-01-29 Arena Pharmaceuticals, Inc. Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
US10894787B2 (en) 2010-09-22 2021-01-19 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
US11884626B2 (en) 2015-06-22 2024-01-30 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders

Also Published As

Publication number Publication date
DE2048375A1 (de) 1971-04-22
FR2070104A1 (fr) 1971-09-10
NL7014541A (fr) 1971-04-06
IL35334A (en) 1974-01-14
CA943067A (en) 1974-03-05
BE756953A (fr) 1971-04-01
IL35334A0 (en) 1971-04-28
FR2070104B1 (fr) 1974-02-22

Similar Documents

Publication Publication Date Title
GB1311956A (en) Method of potentiating the activity of phosphonomycin antibiotics
CA919072A (en) Cushioned track and method for driving same
CA969474A (en) Rumen stable medicament and/or nutrient compositions
ES411065A1 (es) Un procedimiento para la preparacion de acidos 6-(alfa-ome-ga-guanidicroalcanoilaenidonacilamido) penicilanicos.
GB1231943A (fr)
AU467383B2 (en) Method and system for sterilizing magnetically attracted objects
CA977461A (en) Mos semiconductor structure with increased field threshold and method for making the same
GB1231942A (fr)
GB1356909A (en) Process for the preparation of succinylosuccinic acid diesters
GB1139188A (en) Germicidal compositions comprising 1-bromo-3-chloro-5,5-dimethyl hydantoin
GB1275708A (en) Process and compositions for combating dental calculus in animals
CA710830A (en) Disodium and calcium salt of the calcium complex of 2-aminocyclohexyl 2'-aminoethyl ether-n,n,n',n'-tetraacetic acid
GB1312129A (en) Antibiotic and process for preparing same
GR35650B (el) Απορρυπαντικη συνθεσις.
GB1255891A (en) Cyclopentapyrimidine derivative
GB1252495A (fr)
IE38175B1 (en) N-oxides of a benzylpyrimidine
AU436586B2 (en) Bacterial culture extracts
AU4664568A (en) Pasture cultivator
GB1136667A (en) New theophylline derivative
AU5758069A (en) Bacterial culture extracts
CA803986A (en) Method for culturing alkalophilic acid-producing bacteria and their application
CA842165A (en) Ruminant nutrient compositions
CA805666A (en) 6-(3'-methyl-4'-furazanacetamido)-penicillanic acid
CA812016A (en) Rail tractor

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees